510(k) K904036

BARTELS CYTOMEGALOVIRUS IMMED. EARLY ANTIGEN by Baxter Healthcare Corp — Product Code LIN

K904036 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "BARTELS CYTOMEGALOVIRUS IMMED. EARLY ANTIGEN". The FDA issued a decision of Substantially Equivalent on October 16, 1990. The device falls under product code LIN (Antisera, Conjugated Fluorescent, Cytomegalovirus), a Class II device regulated under 21 CFR 866.3175. Baxter Healthcare Corp has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 16, 1990
Date Received
September 5, 1990
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antisera, Conjugated Fluorescent, Cytomegalovirus
Device Class
Class II
Regulation Number
866.3175
Review Panel
MI
Submission Type